REVENUE - Narrative (Details) - USD ($) |
12 Months Ended | |
---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
|
Capitalized Contract Cost [Line Items] | ||
Total revenue recognized from both the beginning balance and current period increase in contract liability | $ 231,711,000 | $ 205,260,000 |
Long-term unearned revenue | $ 37,700,000 | 29,900,000 |
Unearned long-term revenue, recognition period | 5 years | |
Unamortized capitalized costs | $ 22,000,000 | 0 |
Amortization of capitalized costs | 8,600,000 | $ 0 |
Other Current Assets | ||
Capitalized Contract Cost [Line Items] | ||
Unamortized capitalized costs | 15,300,000 | |
Other Assets | ||
Capitalized Contract Cost [Line Items] | ||
Unamortized capitalized costs | $ 6,700,000 |
X | ||||||||||
- Definition Contract With Customer, Liability, Recognition Period No definition available.
|
X | ||||||||||
- Definition Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due, and from current period increase in contract liability. No definition available.
|
X | ||||||||||
- Definition Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|